科技部新聞稿

國際級生醫加速器SmartLabs在臺設立海外第一個據點

日期：108年12月16日

發稿單位：產學及園區業務司

聯絡人：林明徹科長

電話：02-2737-7212

Email：miclin@nstc.gov.tw

科技部與SmartLabs共同建構國際級的生醫新創基地

科技部所引進國際級生醫加速器SmartLabs於今(16)日正式成立籌備處，進駐新竹生醫園區，與科技部共同建構國際級的生醫新創基地，預計明(109)年2月正式啟動SmartLabs海外的第一個營運據點。

SmartLabs選擇臺灣作為其公司海外的第一個據點，也是進軍亞洲的第一站，藉以連結亞洲的新創生態圈，拓展世界版圖。

SmartLabs成立於2015年，來自於美國新創事業聚集的波士頓，是一家專注在生醫領域的公司。曾經培育出世界知名的基因編輯公司，包含：Editas Medicine (EDIT)以及CRISPR Therapeutics (CRSP)。 SmartLabs選擇臺灣作為其公司海外的第一個據點，也是進軍亞洲的第一站，藉以連結亞洲的新創生態圈，拓展世界版圖。 科技部引進SmartLabs進駐，將為臺灣生醫新創公司注入更多創新元素，包括人才、技術及資金，並為臺灣與國際網絡接軌，帶動我國生醫新創產業。

科技部將與SmartLabs共同篩選臺灣具潛力的生技新創團隊，並打造專屬的SmartLabs全球啟動計畫

科技部自107年開始推動「生醫創新聚落整合推動計畫」，積極引進國際生醫加速器以及國際新創公司進駐新竹生醫園區。科技部部長陳良基表示，科技部將與SmartLabs共同篩選臺灣具潛力的生技新創團隊，由SmartLabs為臺灣新創公司打造專屬的SmartLabs全球啟動計畫 (“SmartLabs Global Launch” program)，以國際行銷與通路、專利與法規佈局、募資與財務規劃等三大方向，依照新創團隊的實際需求，提供在地化、客製化，並輔以雲端平台無時差的專業輔導。 優秀團隊更可獲得補助赴美國SmartLabs波士頓總部進行三個月的移地實戰訓練，提升臺灣新創團隊國際競爭實力，也透過SamrtLabs的國際網絡，協助國際資金導入，將臺灣新創團隊推上世界舞台。

Press Release

December 16th, 2019

International Accelerator SmartLabs Establishes First Overseas Office in Taiwan

MOST and SmartLabs will jointly establish an international biomedical innovation base in Hsinchu Biomedical Science Park

SmartLabs, the international biomedical accelerator with which the Ministry of Science and Technology (MOST) has been working to introduce in Taiwan, formally established a preparatory office today (December 16) in the Hsinchu Biomedical Science Park.  SmartLabs and MOST will jointly establish this international biomedical innovation base, and it is expected that the first overseas office of SmartLabs will be launched in February 2020. 

SmartLabs selected Taiwan as its first stop in Asia and its first overseas office, aiming to connect Asia's startup ecosystem and expand its business worldwide. 

Founded in 2015, SmartLabs focuses on the field of biomedical sciences. It is based in Boston, which itself is a hub of innovation-oriented startups. It has incubated world-renowned gene editing companies, including Editas Medicine (EDIT) and CRISPR Therapeutics (CRSP).  SmartLabs selected Taiwan as its first stop in Asia and its first overseas office, aiming to connect Asia's startup ecosystem and expand its business worldwide.  MOST has worked to bring SmartLabs to Taiwan to invest even more innovative elements into Taiwan's biomedical industry, including human and financial resources and R&D collaborations. It will help connect Taiwan with the international community, driving the development of biomedical startups in Taiwan. 

MOST and SmartLabs will work together in screening potential biomedical startups and will conduct a “SmartLabs Global Launch” program for Taiwan startups 

Since 2018, MOST has begun promoting the "Biomedical Cluster Innovation and Integration Plan", actively introducing international biomedical accelerators and international startups to the Hsinchu Biomedical Science Park.  The MOST Minister Liang-Gee Chen remarked that MOST and SmartLabs will work together in screening potential biomedical startups here. And SmartLabs will conduct a “SmartLabs Global Launch” program for Taiwan startups focusing on international marketing and distribution, intellectual property and regulations, as well as fundraising and financial planning.  The nurturing program will be customized to meet the actual needs of each startup team, thereby providing localized and customized assistance, while utilizing a cloud platform to minimize any time lag.  Outstanding teams will receive financial support and be invited to spend another three months at the SmartLabs headquarters in Boston to be engaged in the business.  This will enhance the global competitiveness of Taiwan's startups.  And through the international network, SmartLabs will assist in introducing international investors and help lead Taiwan's startups to the world stage. 

Media Contact

Min-Cheh Lin

Section Chief

Department of Academia-Industry Collaboration and Science Park Affairs,

Ministry of Science and Technology (MOST)

Tel : 886-2-2737-7212

E-mail: miclin@nstc.gov.tw